Chlamydia in Emergency Medicine Follow-up
- Author: Debra E Houry, MD, MPH; Chief Editor: Rick Kulkarni, MD more...
Further Inpatient Care
- Hospitalization is recommended for PID with any of the following factors:
- Tubo-ovarian abscess
- Pregnancy
- Failure of outpatient treatment
- Immunodeficiency
- Severe abdominal pain
- Inability to tolerate PO medications
- Perihepatitis
Further Outpatient Care
- Recheck patients with PID in 1-2 days for signs of clinical improvement.
- All patients should receive follow-up care with a primary care provider to reduce risk of further infection and to screen for cervical cancer.
- Test for chlamydial cure is not necessary unless the patient thinks he or she may have been reinfected.
Deterrence/Prevention
- Condoms (barrier protection) should be used during sexual activities.
- Refer all sexual contacts for testing and treatment.
- Test for other STDs or refer patients for other STD testing.
Complications
- Infertility
- Urethral scarring in men
- PID
- Chronic pelvic pain
- Perihepatitis
- Cervical cancer
Prognosis
- Antibiotic treatment results are 95% effective for first-time therapy. Prognosis is excellent if treatment is initiated early and the entire course of antibiotics is completed.
Patient Education
- Counsel patients regarding the risk of other STDs and transmission of STDs.
- Inform patients of possible long-term risks and complications of their infection, including the possibility of infertility.
- Patients should avoid sexual contact until their treatment is completed and all partners also have been evaluated and treated.
- For patient education resources, see the Sexually Transmitted Diseases Center, as well as Sexually Transmitted Diseases and Chlamydia.
U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Jul 17 2007;147(2):128-34. [Medline]. [Full Text].
Screening for chlamydial infection: recommendation statement. National Guideline Clearinghouse. Available at http://guideline.gov/summary/summary.aspx?doc_id=10408. Accessed March 23, 2009.
Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans--United States, 2000-2007. MMWR Morb Mortal Wkly Rep. Apr 17 2009;58(14):362-5. [Medline]. [Full Text].
(1) Diseases characterized by urethritis and cervicitis. Sexually transmitted diseases treatment guidelines 2006. (2) Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. National Guideline Clearinghouse. Available at http://guideline.gov/summary/summary.aspx?doc_id=10769. Accessed March 23, 2009.
Anttila T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. Jan 3 2001;285(1):47-51. [Medline].
CDC. Sexually transmitted diseases treatment guidelines 2010. Centers for Disease Control and Prevention. MMWR Recomm Rep. Dec 17 2010;59(RR12):1-110.
Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis. Oct 2005;16(4):235-44. [Medline].
Datta SD, Sternberg M, Johnson RE, Berman S, Papp JR, McQuillan G. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. Jul 17 2007;147(2):89-96. [Medline].
Jensen JS, Bjornelius E, Dohn B, Lidbrink P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis. Aug 2004;31(8):499-507. [Medline].
Kelly JJ, Dalsey WC, McComb J, Njuki F. Follow-up program for emergency department patients with gonorrhea or chlamydia. Acad Emerg Med. Dec 2000;7(12):1437-9. [Medline].
Magid D, Douglas JM Jr, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. Ann Intern Med. Feb 15 1996;124(4):389-99. [Medline].
Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA. May 12 2004;291(18):2229-36. [Medline].
Stewart DP. Historical, physical, and laboratory characteristics of female ED patients with positive chlamydia and gonorrhea cultures. Am J Emerg Med. May 1996;14(3):336-7. [Medline].

